GW&K Investment Management’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,209
Closed -$25K 508
2022
Q3
$25K Sell
1,209
-1,691,611
-100% -$35.2M ﹤0.01% 339
2022
Q2
$35.1M Buy
1,692,820
+84,889
+5% +$1.51M 0.38% 117
2022
Q1
$27M Buy
1,607,931
+44,024
+3% +$770K 0.24% 169
2021
Q4
$31.2M Buy
1,563,907
+48,224
+3% +$908K 0.26% 159
2021
Q3
$27.5M Sell
1,515,683
-45,357
-3% -$1.04M 0.25% 164
2021
Q2
$42.1M Buy
1,561,040
+28,976
+2% +$811K 0.37% 116
2021
Q1
$45.9M Sell
1,532,064
-13,849
-0.9% -$472K 0.42% 89
2020
Q4
$44.4M Buy
1,545,913
+426,241
+38% +$11.5M 0.47% 70
2020
Q3
$27.3M Buy
+1,119,672
New +$24.1M 0.36% 114

Other funds holding CVET

GW&K Investment Management's CVET Position: Q4 2022 in Review

GW&K Investment Management sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 1,209 shares — an estimated $25K sold.

GW&K Investment Management first reported a position in CVET in Q3 2020 and held it in 9 quarters. The position peaked at $45.9M in Q1 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • GW&K Investment Management reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • GW&K Investment Management sold 1,209 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $25K.
  • GW&K Investment Management first reported a position in Covetrus, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • GW&K Investment Management's Covetrus, Inc. Common Stock position peaked at $45.9M in Q1 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on GW&K Investment Management's 13F filing for Q4 2022, filed 10 Feb 2023.